Elizabeth A. Winzeler
University of California, San Diego
H-index: 79
North America-United States
Top articles of Elizabeth A. Winzeler
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Reaction hijacking inhibition of Plasmodium falciparum asparagine tRNA synthetase | Nature Communications | Stanley C Xie Yinuo Wang Craig J Morton Riley D Metcalfe Con Dogovski | 2024/1/31 |
Discovery of Potent Antimalarial Type II Kinase Inhibitors with Selectivity over Human Kinases | Journal of Medicinal Chemistry | Lushun Wang Monica J Bohmer Jinhua Wang Flore Nardella Jaeson Calla | 2024/1/12 |
Development of Peptoid-Based Heteroaryl-Decorated Histone Deacetylase (HDAC) Inhibitors with Dual-Stage Antiplasmodial Activity | Daniel Stopper Lais Pessanha de Carvalho Mariana Laureano de Souza Elizabeth Winzeler Jana Held | 2024/4/10 | |
Identification of fungal natural products with potent inhibition in Toxoplasma gondii | Microbiology Spectrum | Tiantian Jiang Karla P Godinez-Macias Jennifer E Collins Jin Woo Lee Karen L Wendt | 2024/2/29 |
CACTI: An in-silico drug-target prediction tool through the integration of chemogenomic data and clustering analysis | bioRxiv | Karla P Godinez Macias Elizabeth A Winzeler | 2024 |
Antiplasmodial peptaibols act through membrane directed mechanisms | Cell Chemical Biology | Jennifer E Collins Jin Woo Lee Frances Rocamora Gagandeep S Saggu Karen L Wendt | 2024/2/15 |
Human polo-like kinase inhibitors as antiplasmodials | ACS Infectious Diseases | Monica J Bohmer Jinhua Wang Eva S Istvan Madeline R Luth Jennifer E Collins | 2023/3/15 |
Targeting aminoacyl tRNA synthetases for antimalarial drug development | Stanley C Xie Michael DW Griffin Elizabeth A Winzeler Lluis Ribas de Pouplana Leann Tilley | 2023/9/15 | |
Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug target | Science translational medicine | Eva S Istvan Francisco Guerra Matthew Abraham Kuo-Sen Huang Frances Rocamora | 2023/3/8 |
Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparum | Nature Communications | Krittikorn Kümpornsin Theerarat Kochakarn Tomas Yeo John Okombo Madeline R Luth | 2023/5/27 |
7-N-Substituted-3-oxadiazole Quinolones with Potent Antimalarial Activity Target the Cytochrome bc1 Complex | ACS Infectious Diseases | William Nguyen Madeline G Dans Iain Currie Jon Kyle Awalt Brodie L Bailey | 2023/2/28 |
Human nuclear hormone receptor activity contributes to malaria parasite liver stage development | Cell chemical biology | Nimisha Mittal Chadwick Davis Peter McLean Jaeson Calla Karla P Godinez-Macias | 2023/5/18 |
Whole-genome surveillance identifies markers of Plasmodium falciparum drug resistance and novel genomic regions under selection in Mozambique | Mbio | Erin Coonahan Hunter Gage Daisy Chen Emilia Virginia Noormahomed Titos Paulo Buene | 2023/10/31 |
Fast-Killing Tyrosine Amide ((S)-SW228703) with Blood- and Liver-Stage Antimalarial Activity Associated with the Cyclic Amine Resistance Locus (PfCARL) | ACS infectious diseases | Leah S Imlay Aloysus K Lawong Suraksha Gahalawat Ashwani Kumar Chao Xing | 2023/2/10 |
Development of Potent and Highly Selective Epoxyketone‐Based Plasmodium Proteasome Inhibitors | Chemistry–A European Journal | Jehad Almaliti Pavla Fajtová Jaeson Calla Gregory M LaMonte Mudong Feng | 2023/4/6 |
Antimalarial drug discovery: Progress and approaches | Jair L Siqueira-Neto Kathryn J Wicht Kelly Chibale Jeremy N Burrows David A Fidock | 2023/10 | |
Potent acyl-CoA synthetase 10 inhibitors kill Plasmodium falciparum by disrupting triglyceride formation | Nature Communications | Selina Bopp Charisse Flerida A Pasaje Robert L Summers Pamela Magistrado-Coxen Kyra A Schindler | 2023/3/16 |
Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance | Elife | Rebecca EK Mandt Madeline R Luth Mark A Tye Ralph Mazitschek Sabine Ottilie | 2023/9/22 |
Plasmodium exoerythrocytic parasites redirect trafficking of human proteins to the parasitophorous vacuole | bioRxiv | Jaeson Calla Nimisha Mittal Greg LaMonte Benjamin Liffner Karla P Godinez-Macias | 2022/11/23 |
Development of Highly Selective Epoxyketone-based Plasmodium Proteasome Inhibitors with Negligible Cytotoxicity | bioRxiv | Jehad Almaliti Pavla Fajtová Jaeson Calla Gregory M LaMonte Mudong Feng | 2022/8/7 |
Co-Authors
